Clinical Trials Browser

Phase 4 × Withdrawn × Toremifene × Clear all

NCT03238703 2018-12-27

Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer

Phase 4 Withdrawn

Breast Carcinoma In Situ, Breast Neoplasms